FDA Label for Swiftalyn Numbing Cream
View Indications, Usage & Precautions
Swiftalyn Numbing Cream Product Label
The following document was submitted to the FDA by the labeler of this product Genuine Innovation Ltd. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Otc - Active Ingredient
Lidocaine 4%
Otc - Purpose
For temporary relief of minor pain, burning and soreness.
Indications & Usage
For use as a local anesthetic to numb the skin prior to minor medical or cosmetic procedures
Warnings
For external use only
Otc - When Using
■ avoid contact with eyes or mucous membranes ■ Use only as directed ■ do not put this product into the rectum by using fingers or any mechanical device or applicator
Otc - Stop Use
■ condition worsens or does not improve within 7 days ■ rectal bleeding occurs ■ allergic reaction occurs to ingredients in this product ■ symptoms being treated do not subside or if redness, irritation, swelling, pain, or other symptoms develop or increase
Otc - Keep Out Of Reach Of Children
If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Dosage & Administration
■ Adults: When practical, clean and dry the affected area. Apply externally to the affected area up to 3 times daily. ■ Children under 12 years of age: consult a doctor.
Other Safety Information
■ Store at room temperature 15–30°C (59–86°F) ■ Keep away from direct sunlight or heat
Inactive Ingredient
Purified Water, Propylene Glycol, Glycerin, Caprylic/Capric Triglyceride, Lecithin, Polysorbate 80, Aloe Vera Leaf Juice, Carbomer, Triethanolamine, Tocopheryl Acetate, Allantoin, Menthol, Phenoxyethanol, Ethylhexylglycerin.
Otc - Questions
Email at:
Package Label.Principal Display Panel
* Please review the disclaimer below.
